Browse > Article
http://dx.doi.org/10.3347/kjp.2016.54.3.291

Construction of In Vivo Fluorescent Imaging of Echinococcus granulosus in a Mouse Model  

Wang, Sibo (Department of General Surgery, First Affiliated Hospital, School of Medicine, Shihezi University)
Yang, Tao (Department of General Surgery, First Affiliated Hospital, School of Medicine, Shihezi University)
Zhang, Xuyong (Department of General Surgery, First Affiliated Hospital, School of Medicine, Shihezi University)
Xia, Jie (Department of General Surgery, First Affiliated Hospital, School of Medicine, Shihezi University)
Guo, Jun (Department of General Surgery, First Affiliated Hospital, School of Medicine, Shihezi University)
Wang, Xiaoyi (Department of General Surgery, First Affiliated Hospital, School of Medicine, Shihezi University)
Hou, Jixue (Department of General Surgery, First Affiliated Hospital, School of Medicine, Shihezi University)
Zhang, Hongwei (Department of General Surgery, First Affiliated Hospital, School of Medicine, Shihezi University)
Chen, Xueling (Department of Immunology, School of Medicine, Shihezi University)
Wu, Xiangwei (Department of General Surgery, First Affiliated Hospital, School of Medicine, Shihezi University)
Publication Information
Parasites, Hosts and Diseases / v.54, no.3, 2016 , pp. 291-299 More about this Journal
Abstract
Human hydatid disease (cystic echinococcosis, CE) is a chronic parasitic infection caused by the larval stage of the cestode Echinococcus granulosus. As the disease mainly affects the liver, approximately 70% of all identified CE cases are detected in this organ. Optical molecular imaging (OMI), a noninvasive imaging technique, has never been used in vivo with the specific molecular markers of CE. Thus, we aimed to construct an in vivo fluorescent imaging mouse model of CE to locate and quantify the presence of the parasites within the liver noninvasively. Drug-treated protoscolices were monitored after marking by JC-1 dye in in vitro and in vivo studies. This work describes for the first time the successful construction of an in vivo model of E. granulosus in a small living experimental animal to achieve dynamic monitoring and observation of multiple time points of the infection course. Using this model, we quantified and analyzed labeled protoscolices based on the intensities of their red and green fluorescence. Interestingly, the ratio of red to green fluorescence intensity not only revealed the location of protoscolices but also determined the viability of the parasites in vivo and in vivo tests. The noninvasive imaging model proposed in this work will be further studied for long-term detection and observation and may potentially be widely utilized in susceptibility testing and therapeutic effect evaluation.
Keywords
Echinococcus granulosus; protoscolex; fluorescent imaging; in vivo; noninvasive; mouse model;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Al-Jawabreh A, Dumaidi K, Ereqat S, Nasereddin A, Al-Jawabreh H, Azmi K, Al-Laham N, Abdeen Z. Incidence of Echinococcus granulosus in domestic dogs in Palestine as revealed by Copro-PCR. PLoS Negl Trop Dis 2015; 9: e0003934.   DOI
2 Grosso G, Gruttadauria S, Biondi A, Marventano S, Mistretta A. Worldwide epidemiology of liver hydatidosis including the Mediterranean area. World J Gastroenterol 2012; 18: 1425-1437.   DOI
3 Eckert J, Conraths FJ, Tackmann K. Echinococcosis: an emerging or re-emerging zoonosis? Int J Parasitol 2000; 30: 1283-1294.   DOI
4 Sadjjadi SM. Present situation of echinococcosis in the Middle East and Arabic North Africa. Parasitol Int 2006; 55(suppl): S197-S202.   DOI
5 Torgerson PR, Karaeva RR, Corkeri N, Abdyjaparov TA, Kuttubaev OT, Shaikenov BS. Human cystic echinococcosis in Kyrgystan: an epidemiological study. Acta Trop 2003; 85: 51-61.   DOI
6 Tunger O. Epidemiology of cystic echinococcosis in the world. Turkiye Parazitol Derg 2013; 37: 47-52 (in Turkish).   DOI
7 Eckert J, Deplazes P. Biological, epidemiological, and clinical aspects of echinococcosis, a zoonosis of increasing concern. Clin Microbiol Rev 2004; 17: 107-135.   DOI
8 Stojkovic M, Zwahlen M, Teggi A, Vutova K, Cretu CM, Virdone R, Nicolaidou P, Cobanoglu N, Junghanss T. Treatment response of cystic echinococcosis to benzimidazoles: a systematic review. PLoS Negl Trop Dis 2009; 3: e524.   DOI
9 Junghanss T, da Silva AM, Horton J, Chiodini PL, Brunetti E. Clinical management of cystic echinococcosis: state of the art, problems, and perspectives. Am J Trop Med Hyg 2008; 79: 301-311.
10 Grozavu C, Ilias M, Pantile D. Multivisceral echinococcosis: concept, diagnosis, management. Chirurgia (Bucur) 2014; 109: 758-768.
11 Falagas ME, Bliziotis IA. Albendazole for the treatment of human echinococcosis: a review of comparative clinical trials. Am J Med Sci 2007; 334: 171-179.   DOI
12 Kourelis TV, Siegel RD. Metformin and cancer: new applications for an old drug. Med Oncol 2012; 29: 1314-1327.   DOI
13 Quinn BJ, Kitagawa H, Memmott RM, Gills JJ, Dennis PA. Repositioning metformin for cancer prevention and treatment. Trends Endocrinol Metab 2013; 24: 469-480.   DOI
14 Massoud TF, Gambhir SS. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 2003; 17: 545-580.   DOI
15 Kasznicki J, Sliwinska A, Drzewoski J. Metformin in cancer prevention and therapy. Ann Transl Med 2014; 2: 57.
16 Keyaerts M, Caveliers V, Lahoutte T. Bioluminescence imaging: looking beyond the light. Trends Mol Med 2012; 18: 164-172.   DOI
17 Chen ZY, Wang YX, Yang F, Lin Y, Zhou QL, Liao YY. New researches and application progress of commonly used optical molecular imaging technology. Biomed Res Int 2014; 2014: 429198.
18 Salani B, Del Rio A, Marini C, Sambuceti G, Cordera R, Maggi D. Metformin, cancer and glucose metabolism. Endocr Relat Cancer 2014; 21: R461-R471.   DOI
19 Gwinn DM, Shackelford DB, Egan DF, Mihaylova MM, Mery A, Vasquez DS, Turk BE, Shaw RJ. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 2008; 30: 214-226.   DOI
20 Cumino AC, Lamenza P, Denegri GM. Identification of functional FKB protein in Echinococcus granulosus: its involvement in the protoscolicidal action of rapamycin derivates and in calcium homeostasis. Int J Parasitol 2010; 40: 651-661.   DOI
21 Reers M, Smith TW, Chen LB. J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential. Biochemistry 1991; 30: 4480-4486.   DOI
22 Perry SW, Norman JP, Barbieri J, Brown EB, Gelbard HA. Mitochondrial membrane potential probes and the proton gradient: a practical usage guide. Biotechniques 2011; 50: 98-115.   DOI
23 El-Mir MY, Nogueira V, Fontaine E, Averet N, Rigoulet M, Leverve X. Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. J Biol Chem 2000; 275: 223-228.   DOI
24 Chan KM, Raikwar SP, Zavazava N. Strategies for differentiating embryonic stem cells (ESC) into insulin-producing cells and development of non-invasive imaging techniques using bioluminescence. Immunol Res 2007; 39: 261-270.   DOI
25 Ceballos L, Virkel G, Elissondo C, Canton C, Canevari J, Murno G, Denegri G,Lanusse C, Alvarez L. A pharmacology-based comparison of the activity of albendazole and flubendazole against Echinococcus granulosus metacestode in sheep. Acta Trop 2013; 127: 216-225.   DOI
26 Elissondo M, Ceballos L, Dopchiz M, Andresiuk V, Alvarez L, Bruni SS, Lanusse C, Denegri G. In vitro and in vivo effects of flubendazole on Echinococcus granulosus metacestodes. Parasitol Res 2007; 100: 1003-1009.   DOI
27 Nicolao MC, Elissondo MC, Denegri GM, Goya AB, Cumino AC. In vitro and in vivo effects of tamoxifen against larval stage Echinococcus granulosus. Antimicrob Agents Chemother 2014; 58: 5146-5154.   DOI
28 Yeh CT, Rao YK, Ye M, Wu WS, Chang TC, Wang LS, Wu CH, Wu AT, Tzeng YM. Preclinical evaluation of destruxin B as a novel Wnt signaling target suppressing proliferation and metastasis of colorectal cancer using non-invasive bioluminescence imaging. Toxicol Appl Pharmacol 2012; 261: 31-41.   DOI